Exclusive: TPG explores $3 billion sale of specialty drugmaker Aptalis

By Jessica Toonkel and Soyoung Kim NEW YORK (Reuters) - TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than $3 billion, four people familiar with the matter said on Wednesday. The private equity firm has been working with JPMorgan Chase & Co and Evercore Partners Inc to find a buyer for the Montreal-based drugmaker in a sale process that has been under way for several months, said the sources, who asked not to be named because the matter is confidential. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/exclusive-tpg-explores-3-billion-sale-specialty-drugmaker-192802826.html